Advertisement

The Indian Journal of Pediatrics

, Volume 73, Issue 3, pp 201–204 | Cite as

Clinical profile and natural history of children with HIV infection

  • Rakesh Lodha
  • Amit Upadhyay
  • Vishal Kapoor
  • S. K. Kabra
Original Article

Abstract

Objective: As the HIV infection spreads in India, increasing number of children are affected. We report the clinical manifestations, the laboratory parameters and follow up of these children.Methods: We reviewed case records of all children diagnosed as pediatric HIV infection since 1995 in our department at a tertiary care hospital in north India. Since, September 1999, all children with HIV infection registered in our clinic were prospectively followed up. Complete clinical and laboratory evaluation was performed at baseline and thereafter children were followed up. The children were managed according to standard treatment guidelines.Results: 109 children (82 boys, 27 girls) were diagnosed to have HIV infection. The median (range) age at presentation was 48 months (range: 0.75 months—180 months). Eighty one (74.3%) children acquired the infection vertically, Ninety-one (83.5%) children were symptomatic at time of presentation. The common symptoms in the former were failure to thrive (81.3%), recurrent fever (73.6%), diarrhea (50.5%) and recurrent or persistent pneumonia (44%). All children had poor nutritional status at baseline. Of the 67 children who followed up, 36 were receiving antiretroviral drugs (32 received 3 drugs), while families of 31 children did not opt for antiretroviral therapy. Children receiving antiretroviral therapy showed improvement in nutritional parameters.Conclusion: Majority of children with HIV infection presented with various clinical manifestations, poor nutritional status and immunosuppression. Administration of nevirapine based antiretroviral therapy leads to improvement in growth and immune restoration.

Key words

HIV Children Antiretrovirals Natural history 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO).AIDS epidemic update: December 2003. UNAIDS, WHO. 2003.Google Scholar
  2. 2.
    NACO. HIV estimates in India 2003. Data accessed from website: http://nacoonline.org/factsnfigures/hivestimates 2003.pdf on September 4 2004.Google Scholar
  3. 3.
    Madhivanan P, Mothi SN, Kumarasamy Net al. Clinical manifestations of HIV infected children.Indian J Pediatr 2003; 70: 615–620.PubMedCrossRefGoogle Scholar
  4. 4.
    Udgirkar VS, Tullu MS, Bavdekar SB, Shaharao VB, Kamat JR, Hira PR. Neurological manifestations of HIV infection.Indian Pediatr 2003; 40: 230–234.PubMedGoogle Scholar
  5. 5.
    Verghese VP, Cherian T, Cherian AJet al. Clinical manifestations of HIV-1 infection.Indian Pediatr 2002; 39: 57–63.PubMedGoogle Scholar
  6. 6.
    Merchant RH, Oswal JS, Bhagwat RV, Karkare J. Clinical profile of HIV infection.Indian Pediatr 2001; 38: 239–246.PubMedGoogle Scholar
  7. 7.
    Lodha R, Singhal T, Jain Y, Kabra SK, Seth P, Seth V. Pediatric HIV infection in a tertiary care center in North India: early impressions.Indian Pediatr 2000; 37: 982–986.PubMedGoogle Scholar
  8. 8.
    Anonymous. Recommendations for the selection and use of HIV antibody tests.WHO Weekly Epidemiol Rec 1992; 20: 145–149.Google Scholar
  9. 9.
    Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center. Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child.Pediatr Infect Dis J 1993; 12: 513–522.CrossRefGoogle Scholar
  10. 10.
    Working Group on Antiretroviral Therapy and Medical Management of HIV-infected children. Antiretroviral therapy and medical management of pediatric HIV infection.Pediatrics 1998; 102: 1005–1062.Google Scholar
  11. 11.
    USPHS/IDSA Prevention of Opportunistic Infections Working Group. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: A summary.MMWR 1995; 44 (No. RR 8).Google Scholar
  12. 12.
    1997 USPHS/IDSA Report on Prevention of Opportunistic Infections in Patients Infected with Human Immunodeficiency Virus.Pediatrics 1998; 102: 1064–1086.Google Scholar
  13. 13.
    Barnhart HX, Caldwell MB, Thomas Pet al. Natural history of human immunodeficiency virus disease in perinatally infected children: An analysis from the Pediatric Spectrum of Disease Project.Pediatrics 1996; 97: 710–716.PubMedGoogle Scholar
  14. 14.
    Tovo PA, Martino M, Gabiano Cet al. Prognostic factors and survival in children with perinatal HIV-1 infection.Lancet 1992; 339: 1249–1252.PubMedCrossRefGoogle Scholar
  15. 15.
    Italian Register for HIV infection in children. Features of children perinatally infected with HIV-1 surviving longer than 5 years.Lancet 1994; 343: 191–195.Google Scholar
  16. 16.
    Emodi IJ, Okafor GO. Clinical manifestations of HIV infection in children at Enugu, Nigeria.J Trop Pediatr 1998; 44: 73–76.PubMedCrossRefGoogle Scholar
  17. 17.
    Lambert HJ, Friesen H. Clinical features of pediatric AIDS in Uganda.Ann Trop Paediatr 1989; 9: 1–5.PubMedGoogle Scholar
  18. 18.
    Berhane R, Bagenda D, Marum Let al. Growth failure as a prognostic indicator of mortality in pediatric HIV infection. Pediatrics. 1997; 100: e7.PubMedCrossRefGoogle Scholar
  19. 19.
    Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.Pediatrics 2002; 109: e25.PubMedCrossRefGoogle Scholar
  20. 20.
    Buchacz K, Cervia JS, Lindsey JCet al. Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children. Pediatrics 2001; 108: e72.PubMedCrossRefGoogle Scholar
  21. 21.
    Van Rossum AM, Gaakeer MI, Verweel Set al. Endocrinologic and immunologic factors associated with recovery of growth in children with human immunodeficiency virus type 1 infection treated with protease inhibitors.Pediatr Infect Dis J 2003; 22: 70–76.PubMedCrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2006

Authors and Affiliations

  • Rakesh Lodha
    • 1
  • Amit Upadhyay
    • 1
  • Vishal Kapoor
    • 1
  • S. K. Kabra
    • 1
  1. 1.Department of PediatricsAll India, Institute of Medical SciencesNew Delhi

Personalised recommendations